{"id":523109,"date":"2021-08-04T09:04:02","date_gmt":"2021-08-04T13:04:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\/"},"modified":"2021-08-04T09:04:02","modified_gmt":"2021-08-04T13:04:02","slug":"tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\/","title":{"rendered":"TFF Pharmaceuticals to Hold Second Quarter 2021 Financial and Business Results Conference Call on August 12, 2021"},"content":{"rendered":"

\nCompany conference call and webcast at\u00a04:30 PM EDT
\n<\/h2>\n
\n

AUSTIN, Texas, Aug. 04, 2021 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc.\u00a0(NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that it will release its financial results and business update for the second quarter of 2021 on\u00a0Thursday, August 12, 2021,\u00a0at the close of the\u00a0U.S.\u00a0financial markets.<\/p>\n

Management will host a conference call to discuss the financial results and provide an update on recent corporate and clinical developments at\u00a04:30 PM EDT. A question-and-answer session with investors will follow management\u2019s remarks.<\/p>\n

\n Conference Call and Webcast Information <\/strong>\n <\/p>\n

The Company will host a conference call on Thursday, August 12, 2021, at 4:30 PM EDT to review the clinical, corporate and financial highlights. To participate in the conference call, please dial the following numbers prior to the start of the call:<\/p>\n

Domestic Dial-In Number: Toll-Free: (866) 269-4261
International Dial-In Number (323) 289-6581
Conference ID: 6229028<\/p>\n

The call will also be broadcast live over the Web and can be accessed on TFF Pharmaceuticals\u2019 Website, https:\/\/tffpharma.com<\/strong><\/a> or directly at http:\/\/public.viavid.com\/index.php?id=146022<\/strong><\/a>. Please access the Company’s website at least 15 minutes ahead of the conference to register, download, and install any necessary audio software. The conference call will also be available for replay for\u00a0one month\u00a0on the Company’s website in the\u00a0Events Calendar of the Investors section.<\/p>\n

\n About TFF Pharmaceuticals\u2019 Thin Film Freezing technology platform <\/strong>\n <\/p>\n

TFF Pharmaceuticals\u2019 Thin Film Freezing (TFF) platform was designed to improve the solubility and absorption of poorly water-soluble drugs and is particularly suited to generate dry powder particles with properties targeted for inhalation delivery, especially to the deep lung, an area of extreme interest in respiratory medicine. The TFF process results in a \u201cBrittle Matrix Particle,\u201d which possesses low bulk density, high surface area, and typically an amorphous morphology, allowing the particles to supersaturate when contacting the target site, such as lung tissue. Based upon laboratory experiments the aerodynamic properties of the particles are such that the portion of a drug deposited to the deep lung has the potential to reach as high as 75 percent.<\/p>\n

\n About TFF Pharmaceuticals<\/strong>\n <\/p>\n

TFF Pharmaceuticals, Inc.\u00a0is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing, or TFF, technology platform. Early testing confirms that the TFF platform can significantly improve the solubility and absorption of poorly water-soluble drugs, a class of drugs that comprises approximately one-third of the major pharmaceuticals worldwide, thereby improving their pharmacokinetics.\u00a0TFF Pharmaceuticals\u00a0has two lead drug candidates: Voriconazole Inhalation Powder and Tac-Lac Inhalation Powder. The Company plans to add to this pipeline by collaborating with large pharmaceutical partners. The TFF Platform is protected by 42 patents issued or pending in the US and internationally. To learn more about\u00a0TFF Pharmaceuticals\u00a0and its product candidates, visit the Company\u2019s website at https:\/\/tffpharma.com<\/strong><\/a>.<\/a><\/p>\n

\n SAFE HARBOR <\/strong>\n <\/p>\n

This press release contains forward-looking statements regarding\u00a0TFF Pharmaceuticals, Inc., including the benefits of the Company\u2019s TFF platform and its dry powder versions of Tacrolimus, and the Company\u2019s plans to add to its existing pipeline of product candidates. Those forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (i) the risk that the Company may not be able to successfully conclude clinical testing or obtain pre-market approval of its dry powder versions of Tacrolimus, (ii) no drug product incorporating the TFF platform has received FDA pre-market approval or otherwise been incorporated into a commercial drug product, (iii) the Company has no current agreements or understandings with any large pharmaceutical companies for the development of a drug product incorporating the TFF Platform, (iv) the risk that the Company will not be able to conclude a long-term commercial agreement with any third-party, and (v) those other risks disclosed in the section \u201cRisk Factors\u201d included in the Company\u2019s 2020 Annual Report on Form 10-K filed with the\u00a0SEC\u00a0on\u00a0March 10, 2021.\u00a0TFF Pharmaceuticals\u00a0cautions readers not to place undue reliance on any forward-looking statements.\u00a0TFF Pharmaceuticals\u00a0does not undertake, and specifically disclaims, any obligation to update or revise such statements to reflect new circumstances or unanticipated events as they occur, except as required by law.<\/p>\n

\n Company Contacts:<\/strong>
\n
Glenn Mattes President\u00a0and CEO
TFF Pharmaceuticals, Inc.
gmattes@tffpharma.com<\/a>
737-802-1973<\/p>\n

Kirk Coleman
Chief Financial Officer
TFF Pharmaceuticals, Inc.
kcoleman@tffpharma.com<\/a>
817-989-6358<\/p>\n

\n Investor Relations:<\/strong>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0
Corey Davis, Ph.D.\u00a0
LifeSci Advisors\u00a0
cdavis@lifesciadvisors.com<\/a>
212-915-2577\u00a0<\/p>\n

\n Media Contact:<\/strong>
\n
Gwendolyn Schanker
LifeSci Communications
(269) 921-3607
gschanker@lifescicomms.com<\/a><\/p>\n

Source:\u00a0TFF Pharmaceuticals, Inc.<\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Company conference call and webcast at\u00a04:30 PM EDT AUSTIN, Texas, Aug. 04, 2021 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc.\u00a0(NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that it will release its financial results and business update for the second quarter of 2021 on\u00a0Thursday, August 12, 2021,\u00a0at the close of the\u00a0U.S.\u00a0financial markets. Management will host a conference call to discuss the financial results and provide an update on recent corporate and clinical developments at\u00a04:30 PM EDT. A question-and-answer session with investors will follow management\u2019s remarks. Conference Call and Webcast Information The Company will host a conference call on Thursday, August 12, 2021, at … <\/p>\n

Continue reading “TFF Pharmaceuticals to Hold Second Quarter 2021 Financial and Business Results Conference Call on August 12, 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-523109","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nTFF Pharmaceuticals to Hold Second Quarter 2021 Financial and Business Results Conference Call on August 12, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TFF Pharmaceuticals to Hold Second Quarter 2021 Financial and Business Results Conference Call on August 12, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Company conference call and webcast at\u00a04:30 PM EDT AUSTIN, Texas, Aug. 04, 2021 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc.\u00a0(NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that it will release its financial results and business update for the second quarter of 2021 on\u00a0Thursday, August 12, 2021,\u00a0at the close of the\u00a0U.S.\u00a0financial markets. Management will host a conference call to discuss the financial results and provide an update on recent corporate and clinical developments at\u00a04:30 PM EDT. A question-and-answer session with investors will follow management\u2019s remarks. Conference Call and Webcast Information The Company will host a conference call on Thursday, August 12, 2021, at … Continue reading "TFF Pharmaceuticals to Hold Second Quarter 2021 Financial and Business Results Conference Call on August 12, 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-04T13:04:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjU4NiM0MzQwODA2IzUwMDA4MDQ2Mg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"TFF Pharmaceuticals to Hold Second Quarter 2021 Financial and Business Results Conference Call on August 12, 2021\",\"datePublished\":\"2021-08-04T13:04:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\\\/\"},\"wordCount\":779,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMjU4NiM0MzQwODA2IzUwMDA4MDQ2Mg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\\\/\",\"name\":\"TFF Pharmaceuticals to Hold Second Quarter 2021 Financial and Business Results Conference Call on August 12, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMjU4NiM0MzQwODA2IzUwMDA4MDQ2Mg==\",\"datePublished\":\"2021-08-04T13:04:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMjU4NiM0MzQwODA2IzUwMDA4MDQ2Mg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMjU4NiM0MzQwODA2IzUwMDA4MDQ2Mg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TFF Pharmaceuticals to Hold Second Quarter 2021 Financial and Business Results Conference Call on August 12, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TFF Pharmaceuticals to Hold Second Quarter 2021 Financial and Business Results Conference Call on August 12, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\/","og_locale":"en_US","og_type":"article","og_title":"TFF Pharmaceuticals to Hold Second Quarter 2021 Financial and Business Results Conference Call on August 12, 2021 - Market Newsdesk","og_description":"Company conference call and webcast at\u00a04:30 PM EDT AUSTIN, Texas, Aug. 04, 2021 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc.\u00a0(NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that it will release its financial results and business update for the second quarter of 2021 on\u00a0Thursday, August 12, 2021,\u00a0at the close of the\u00a0U.S.\u00a0financial markets. Management will host a conference call to discuss the financial results and provide an update on recent corporate and clinical developments at\u00a04:30 PM EDT. A question-and-answer session with investors will follow management\u2019s remarks. Conference Call and Webcast Information The Company will host a conference call on Thursday, August 12, 2021, at … Continue reading \"TFF Pharmaceuticals to Hold Second Quarter 2021 Financial and Business Results Conference Call on August 12, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-04T13:04:02+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjU4NiM0MzQwODA2IzUwMDA4MDQ2Mg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"TFF Pharmaceuticals to Hold Second Quarter 2021 Financial and Business Results Conference Call on August 12, 2021","datePublished":"2021-08-04T13:04:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\/"},"wordCount":779,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjU4NiM0MzQwODA2IzUwMDA4MDQ2Mg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\/","name":"TFF Pharmaceuticals to Hold Second Quarter 2021 Financial and Business Results Conference Call on August 12, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjU4NiM0MzQwODA2IzUwMDA4MDQ2Mg==","datePublished":"2021-08-04T13:04:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjU4NiM0MzQwODA2IzUwMDA4MDQ2Mg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjU4NiM0MzQwODA2IzUwMDA4MDQ2Mg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-hold-second-quarter-2021-financial-and-business-results-conference-call-on-august-12-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"TFF Pharmaceuticals to Hold Second Quarter 2021 Financial and Business Results Conference Call on August 12, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/523109","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=523109"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/523109\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=523109"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=523109"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=523109"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}